Richard W Simpson

1.8k total citations
18 papers, 975 citations indexed

About

Richard W Simpson is a scholar working on Endocrinology, Diabetes and Metabolism, Cellular and Molecular Neuroscience and Immunology. According to data from OpenAlex, Richard W Simpson has authored 18 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Immunology. Recurrent topics in Richard W Simpson's work include Diabetes Treatment and Management (8 papers), Apelin-related biomedical research (3 papers) and Nuclear Receptors and Signaling (3 papers). Richard W Simpson is often cited by papers focused on Diabetes Treatment and Management (8 papers), Apelin-related biomedical research (3 papers) and Nuclear Receptors and Signaling (3 papers). Richard W Simpson collaborates with scholars based in Australia, Denmark and United Kingdom. Richard W Simpson's co-authors include Anthony E. Dear, Robert E. Widdop, Tracey A. Gaspari, Lotte Bjerre Knudsen, Yunshan Hu, Iresha Welungoda, Hongbin Liu, Hongbin Liu, Graeme C. Smith and Jonathan E. Shaw and has published in prestigious journals such as Diabetes Care, Cell and Tissue Research and Journal of Endocrinology.

In The Last Decade

Richard W Simpson

18 papers receiving 955 citations

Peers

Richard W Simpson
A Casolaro Italy
W Waldhäusl Austria
Antoine Makdissi United States
Hidenori Yoshii Japan
Tetsuyuki Yasuda Japan
Tsunehiko Yamamoto Japan
Oliver Götze Germany
Yasuyuki Tsujita Japan
Duncan J. Campbell Australia
Kohei Okita Japan
A Casolaro Italy
Richard W Simpson
Citations per year, relative to Richard W Simpson Richard W Simpson (= 1×) peers A Casolaro

Countries citing papers authored by Richard W Simpson

Since Specialization
Citations

This map shows the geographic impact of Richard W Simpson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard W Simpson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard W Simpson more than expected).

Fields of papers citing papers by Richard W Simpson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard W Simpson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard W Simpson. The network helps show where Richard W Simpson may publish in the future.

Co-authorship network of co-authors of Richard W Simpson

This figure shows the co-authorship network connecting the top 25 collaborators of Richard W Simpson. A scholar is included among the top collaborators of Richard W Simpson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard W Simpson. Richard W Simpson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gaspari, Tracey A., Hongbin Liu, Yunshan Hu, et al.. (2017). Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: A potential mechanism for inhibition of atherogenesis. Diabetes and Vascular Disease Research. 15(1). 64–73. 108 indexed citations
2.
Meeren, Olivier Van Der, James T. Peterson, Marc Dionne, et al.. (2016). Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus. Human Vaccines & Immunotherapeutics. 12(8). 2197–2203. 24 indexed citations
3.
4.
5.
Gaspari, Tracey A., et al.. (2015). Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis. Diabetes and Vascular Disease Research. 13(1). 56–68. 38 indexed citations
6.
Simpson, Richard W, Geoffrey C. Nicholson, Joseph Proietto, et al.. (2014). Efficacy and Safety of Oral Methazolamide in Patients With Type 2 Diabetes: A 24-Week, Placebo-Controlled, Double-Blind Study. Diabetes Care. 37(11). 3121–3123. 13 indexed citations
7.
Gaspari, Tracey A., Iresha Welungoda, Robert E. Widdop, Richard W Simpson, & Anthony E. Dear. (2013). The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE−/− mouse model. Diabetes and Vascular Disease Research. 10(4). 353–360. 125 indexed citations
8.
Gaspari, Tracey A., Iresha Welungoda, Yunshan Hu, et al.. (2011). A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model. Diabetes and Vascular Disease Research. 8(2). 117–124. 163 indexed citations
9.
Hu, Yong, et al.. (2010). PPAR -independent thiazolidinedione-mediated inhibition of NUR77 expression in vascular endothelial cells. Journal of Endocrinology. 208(1). R1–R7. 6 indexed citations
10.
Liu, Hongbin, Yunshan Hu, Richard W Simpson, & Anthony E. Dear. (2010). Glucagon-like peptide-1 attenuates tumour necrosis factor-α-mediated induction of plasmogen activator inhibitor-1 expression. Journal of Endocrinology. 206(2). 248–248. 6 indexed citations
11.
Liu, Hongbin, Anthony E. Dear, Lotte Bjerre Knudsen, & Richard W Simpson. (2009). A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules. Journal of Endocrinology. 201(1). 59–66. 157 indexed citations
12.
Topliss, Duncan J., et al.. (2008). Gonadotroph Adenoma in Multiple Endocrine Neoplasia Type 1. Endocrine Practice. 14(5). 592–594. 3 indexed citations
13.
Liu, Hongbin, Yunshan Hu, Richard W Simpson, & Anthony E. Dear. (2007). Glucagon-like peptide-1 attenuates tumour necrosis factor-α-mediated induction of plasmogen activator inhibitor-1 expression. Journal of Endocrinology. 196(1). 57–65. 59 indexed citations
14.
Simpson, Richard W, Jonathan E. Shaw, & Paul Zimmet. (2003). The prevention of type 2 diabetes — lifestyle change or pharmacotherapy? A challenge for the 21st century. Diabetes Research and Clinical Practice. 59(3). 165–180. 70 indexed citations
15.
Wilson, J. D., et al.. (1982). Familial Optic Atrophy with Diabetes Mellitus. Australian and New Zealand Journal of Medicine. 12(1). 48–51. 3 indexed citations
16.
Ward, Lizzie, et al.. (1980). Clinic- Rather than Self-Monitoring of Home Blood Samples: Relevance of Day-to-Day Variability to Decision Making. Diabetes Care. 3(1). 171–174. 7 indexed citations
17.
Simpson, Richard W, et al.. (1978). Psittacosis masquerading as rheumatic fever.. BMJ. 1(6114). 694.2–695. 8 indexed citations
18.
Smith, Graeme C. & Richard W Simpson. (1970). Monoamine fluorescence in the median eminence of foetal, neonatal and adult rats. Cell and Tissue Research. 104(4). 541–556. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Casolaro Breakdown of academic impact, for papers by W Waldhäusl Breakdown of academic impact, for papers by Antoine Makdissi Breakdown of academic impact, for papers by Hidenori Yoshii Breakdown of academic impact, for papers by Tetsuyuki Yasuda Breakdown of academic impact, for papers by Tsunehiko Yamamoto Breakdown of academic impact, for papers by Oliver Götze Breakdown of academic impact, for papers by Yasuyuki Tsujita Breakdown of academic impact, for papers by Duncan J. Campbell Breakdown of academic impact, for papers by Kohei Okita
Rankless by CCL
2026